Looking back on immuno-oncology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Regeneron ...

F M Investments LLC ramped up its Lockheed Martin holdings by 33.6% in Q4, adding nearly 3,000 shares worth $5.7 million.